INTERLEUKIN-6

There are 4 papers on INTERLEUKIN-6 in aging research: none in people yet, 2 in animals, 2 reviews.

Gene

4 papers study it4 findings

See all 4 papers on INTERLEUKIN-6

At a glance

The findings reach mice, none yet in people. 2 independent labs in 2 countries.

None of its findings points the other way.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 2 independent labs in 2 countries
  • Funders: National Key Research and Development Program of China and 2 more
  • Animals2

Effects

3

Cognitive function

downin mice1

1 study
  1. INTERLEUKIN-6 impairs cognitive function in mice (shown by recombinant IL-6 abolishing the A. muciniphila benefit).

    “an IL-6 recombinant protein abolished the protective effect of A. muciniphila on cognitive function in aged mice”

    Animalsshown by recombinant IL-6 abolishing the A. muciniphila benefitrecombinant protein

    Akkermansia muciniphila, which is enriched in the gut microbiota by metformin, improves cognitive function in aged mice by reducing the proinflammatory cytokine interleukin-6

    Microbiome

Microglia number

upin mice1

1 study
  1. INTERLEUKIN-6 increases microglia number in mice (constitutive IL6 expression in GFAP-IL6 transgenic mice versus wild-type littermates) (approximately 5-fold).

    “We found that the total number of microglia increased by approximately 5 times in the cerebellum of GFAP-IL6 mice compared to their WT littermates.”

    Animalsconstitutive IL6 expression in GFAP-IL6 transgenic mice versus wild-type littermatescerebellum

    The effect of aging and chronic microglia activation on the morphology and numbers of the cerebellar Purkinje cells

    Neuroscience letters

Tumor niche signaling between cancer cells and non-malignant neighbors

mediatesin humans1

1 study
  1. INTERLEUKIN-6 mediates tumor niche signaling between cancer cells and non-malignant neighbors in humans.

    “IL-6 also represents one of the main signals in communication between cancer cells and their non-malignant neighbours within the tumour niche.”

    Review

    Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19

    International journal of molecular sciences

Associations

1

Fatal outcome in severe COVID-19

upin humans1

1 study
  1. INTERLEUKIN-6 raises the risk of fatal outcome in severe COVID-19 in humans (cytokine storm in severe COVID-19).

    “IL-6 is a fundamental factor of the cytokine storm in patients with severe COVID-19, where it is responsible for the fatal outcome of the disease.”

    Reviewcytokine storm in severe COVID-19

    Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19

    International journal of molecular sciences

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 0Nov 2026: 01 paper in 12 months